37 - COVID-19 Vaccines and Treatment

Rapid Fire Moderator(s)

• 

  Michael Ison, MD MS (he/him/his)

  Chief
  Respiratory Diseases Branch, DMID/NIAID/NIH
  Derwood, MD, United States

Presentations:

• 12:15 PM – 12:20 PM US ET

  Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life
  

  Rapid Fire Presenter: Cristina Cardemil, MD, MPH (she/her/hers) – National Institutes of Health

  Co-Author: Flor M. Munoz, MD, MSc – Baylor College of Medicine

  Co-Author: Yi Cao, PhD – Fred Hutchinson Cancer Center

  Co-Author: Fei Gao, Ph.D. – Fred Hutchinson Cancer Center

  Co-Author: Christine M. Posavad, PhD – Fred Hutchinson Cancer Center

  Co-Author: Martina L. Badell, MD – Emory University School of Medicine

  Co-Author: Katherine E. Bunge, MD – University of Pittsburgh

  Co-Author: Mark J. Mulligan, M.D. – NYU Grossman School of Medicine

  Co-Author: Lalitha Parameswaran, MD, MPH – NYU Langone Health, NYU Langone Vaccine Center

  Co-Author: Courtney Olson-Chen, MD, MSCI – University of Rochester

  Co-Author: Richard M. Novak, MD – University of illinois at Chicago

  Co-Author: Rebecca C. Brady, MD – CIncinnati Children's Hospital Medical Center

  Co-Author: Emily A. DeFranco, D.O. – Cincinnati Children’s Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine

  Co-Author: Jeffrey S. Gerber, MD, PhD – Children's Hospital of Philadelphia

  Co-Author: Marcela Pasetti, PhD – University of Maryland

  Co-Author: Mallory C. Shriver, MSc – University of Maryland School of Medicine

  Co-Author: Rhea Coler, PhD – Seattle Children’s Research Institute, Center for Global Infectious Disease Research

  Co-Author: Bryan J. Berube, PhD – Seattle Children's Research Institute

  Co-Author: Barbra A. Richardson, PhD – University of Washington

  Co-Author: Richard H. Beigi, M.D. – UPMC Magee-Womens Hospital

  Co-Author: Kathy M. Neuzil, MD, MPH – University of Maryland School of Medicine

  Co-Author: Elizabeth R. Brown, ScD – Fred Hutchinson Cancer Center
• 12:20 PM – 12:25 PM US ET

  Nirmatrelvir/ritonavir or Molnupiravir for Treatment of Non-hospitalized Patients with COVID-19 at Risk of Disease Progression
  

  Rapid Fire Presenter: Adeel A. Butt, MBBS, MS – VA Pittsburgh Healthcare System

  Co-Author: Peng Yan, MD, MS – VA Pittsburgh Healthcare System

  Co-Author: Obaid Shaikh, MD – VA Pittsburgh Healthcare System
• 12:25 PM – 12:30 PM US ET

  Predicting the Public Health Impact of Bivalent Vaccines and Nirmatrelvir-Ritonavir against COVID-19
  

  Co-Author: Hailey J. Park, BA – University of California, San Francisco

  Co-Author: Sophia T. Tan, BA – University of California, San Francisco

  Co-Author: Tomás M. León, PhD – California Department of Public Health

  Co-Author: Seema Jain, MD, FIDSA – California Department of Public Health

  Co-Author: Robert Schechter, MD, MSc – California Department of Public Health

  Rapid Fire Presenter: Nathan C. Lo, MD PhD (he/him/his) – Stanford University
• 12:30 PM – 12:35 PM US ET

  Phenotypic Clusters of Clinical Presentation and Severity Among Children with Multisystem Inflammatory Syndrome — United States, February 2020–October 2022
  

  Rapid Fire Presenter: Kevin Ma, PhD – Centers for Disease Control and Prevention

  Co-Author: Anna R. Yousaf, MD (she/her/hers) – Centers for Disease Control and Prevention

  Co-Author: Katherine N. Lindsey, MPH – Centers for Disease Control and Prevention

  Co-Author: Michael Melgar, MD (he/him/his) – Centers for Disease Control and Prevention

  Co-Author: Allison D. Miller, MPH – Centers for Disease Control and Prevention

  Co-Author: Ami B. Shah, MPH – General Dynamics Information Technology

  Co-Author: Michael J. Wu, MSc – Centers for Disease Control and Prevention

  Co-Author: Angela P. Campbell, MD, MPH, FPIDS, FIDSA – Centers for Disease Control and Prevention

  Co-Author: Laura D. Zambrano, PhD, MPH (she/her/hers) – Centers for Disease Control and Prevention
• 12:35 PM – 12:40 PM US ET

  Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
  

  Rapid Fire Presenter: Kristen Andreatta, MS – Gilead Sciences, Inc.

  Co-Author: Jiani Li, PhD – Gilead Sciences, Inc.

  Co-Author: Lauren Rodriguez, PhD – Gilead Sciences, Inc.

  Co-Author: Dong Han, MS – Gilead Sciences, Inc.

  Co-Author: Simin Xu, MS – Gilead Sciences, Inc.

  Co-Author: Jason K. Perry, PhD – Gilead Sciences, Inc.

  Co-Author: Yiannis Koullias, MD – Gilead Sciences, Inc.

  Co-Author: Robert H. Hyland, DPhil – Gilead Sciences, Inc.

  Co-Author: Charlotte Hedskog, PhD (she/her/hers) – Gilead Sciences, Inc.
• 12:40 PM – 12:45 PM US ET

  "Longitudinal Investigation of Avidity Maturation following Multiple Doses of BNT162b2 mRNA Vaccine Including Bivalent Boosters among Nursing Home Residents and Healthcare Workers"
  

  Rapid Fire Presenter: Oladayo A. Oyebanji, MBChB, MS (he/him/his) – Case Western Reserve University

  Co-Author: Vaishnavi Ragavapuram, MS – Case Western Reserve University

  Co-Author: Nicholas Sundheimer, BS – Case Western Reserve University

  Co-Author: Jürgen Bosch, PhD, MBA – Case Western Reserve University

  Co-Author: Brigid Wilson, PhD (she/her/hers) – VA Northeast Ohio Healthcare System

  Co-Author: Stefan Gravenstein, MD, MPH – Brown University

  Co-Author: Christopher King, MD – Case Western Reserve University

  Co-Author: David Canaday, MD – VA Northeast Ohio Healthcare System